Automatic Quantitative Analysis software for Alzheimer’s Disease
Heuron-Alzheimer provides information by PET & 3D T1 MRI-based
imaging for Alzheimer's Disease.
This solution automatically quantifies multi-tracer bindings localized to 97 brain segmentation and 4 reference regions identified by 3D T1 MRI segmentation.
- FDA, CE, MFDS approved
- Commercially available
Amyloid beta, biomarker for Alzheimer's Disease
Alzheimer's Disease(AD) pathogenesis is widely believed to be driven by the production
and deposition of the amyloid beta plaque.
Amyloid beta is the first protein that begins to accumulate when Alzheimer's
Disease(AD) is contracted, and it is used as an important biomarker in diagnosing Alzheimer's Disease(AD) .
'Heuron-Alzheimer' analyzes amyloid PET images and presents quantitative results to support diagnosis and clinical trials.
and deposition of the amyloid beta plaque.
Amyloid beta is the first protein that begins to accumulate when Alzheimer's
Disease(AD) is contracted, and it is used as an important biomarker in diagnosing Alzheimer's Disease(AD) .
'Heuron-Alzheimer' analyzes amyloid PET images and presents quantitative results to support diagnosis and clinical trials.
